Vinge represents Ellevio in the acquisition of Markbygden Net Väst AB, a network company that connects to the national grid via Svenska kraftnät's station in Trolltjärn outside Arvidsjaur, from Enercon.

Ellevio is one of Sweden's largest electricity network companies, and through the acquisition, Ellevio strengthens its role as a leading player in the Swedish energy transition and the path towards net-zero emissions by 2045. 

Vinge's team consisted of Peter Sundgren (Energy/M&A) together with Gustav Persson and Ida Appelgren (M&A), Johan Cederblad and Lina Österberg (Permits and Environmental Law), Kristoffer Larson and Hanna Kövamees (Real Estate Law), Fredrika Hjelmberg and Siri Blomberg (IT and GDPR), Mario Saad and Jolene Reimerson (Commercial Agreements), Daniel Wendelsson, Dagne Sabockis, Alva Chambert, and Isabell Åkerblom (FDI), Kristoffer Sällfors (Public Procurement), Carl Johan af Petersens and Andrea Rökaas (Regulatory), Niclas Lindblom (Construction Law), Ian Jonson (IP), Amelia Rihs (Labor Law), August Ahlin (Banking and Finance), Gulestan Ali and Jonna Fransson (Compliance), Caroline Löv (Transaction Support).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025